The Valley Desk

NCT03346057 · Interventional trial

Safety of Sugammadex for the Reversal of Neuromuscular Blockade in American Society of Anesthesiologists (ASA) Class 3 or 4 Participants (MK-8616-145)

Overall registry status Completed

Phase 4

Conditions Reversal of Neuromuscular Blockade

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov